Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$25.26 - $29.6 $396,506 - $464,631
15,697 New
15,697 $439,000
Q2 2023

Aug 08, 2023

SELL
$36.12 - $41.79 $7,223 - $8,358
-200 Reduced 3.23%
5,997 $220,000
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $41,750 - $54,500
-1,000 Reduced 13.89%
6,197 $318,000
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $41,572 - $50,749
-950 Reduced 11.66%
7,197 $315,000
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $3,349 - $3,777
-100 Reduced 1.21%
8,147 $295,000
Q4 2020

Feb 26, 2021

SELL
$33.47 - $42.56 $272,747 - $346,821
-8,149 Reduced 49.7%
8,247 $304,000
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $330,200 - $387,400
10,400 Added 66.25%
26,097 $958,000
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $308,006 - $361,362
-9,701 Reduced 37.17%
16,396 $642,000
Q2 2020

Aug 18, 2020

SELL
$30.12 - $36.54 $21,053 - $25,541
-699 Reduced 4.26%
15,697 $513,000
Q4 2019

Feb 11, 2020

SELL
$32.92 - $37.36 $83,452 - $94,707
-2,535 Reduced 13.39%
16,396 $642,000
Q3 2019

Nov 15, 2019

SELL
$32.49 - $42.13 $4,873 - $6,319
-150 Reduced 0.79%
18,931 $680,000
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $1.13 Million - $1.24 Million
-30,000 Reduced 61.12%
19,081 $810,000
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $50,318 - $57,368
-1,308 Reduced 2.6%
49,081 $2.14 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $97,033 - $117,695
-2,815 Reduced 5.29%
50,389 $2.22 Million
Q1 2018

May 17, 2018

SELL
$31.91 - $37.02 $210,606 - $244,332
-6,600 Reduced 11.04%
53,204 $1.89 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $1.85 Million - $2.04 Million
59,804
59,804 $2.14 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Doheny Asset Management /Ca Portfolio

Follow Doheny Asset Management /Ca and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Doheny Asset Management /Ca, based on Form 13F filings with the SEC.

News

Stay updated on Doheny Asset Management /Ca with notifications on news.